HE News Icon

HEOR News Roundup

Tuesday, Nov. 17, 2020 | Issue 528

email icon Twitter icon Facebook icon LinkedIn Icon Subscribe Contact Advertise HEOR & RWE Marketplace

Sponsored by

ICON Newsletter Banner

The Emergence of ICER in American Pharma

Joe Biden recently suggested that Medicare drug-price negotiations should follow the German model where negotiations between government and drugmakers are informed by a third-party independent analysis.

Read More

Michael L. Ryan of Bristol Myers Squibb Elected Board Chair of National Pharmaceutical Council

[Podcast] How To Best Launch a Therapy For an Ultra-rare Disease?

Value Assessment in the Context of COVID-19

Indication-Based Pricing Gaining Support in UK

HEOR news icon
Featured Events



Using Patient Preferences to Inform Decision Making

November 20


HTA and Market Access Implications for Gene Therapies: Learnings for Future Products

December 8


NPC Banner
Conferences Webinars
University of FL
What we're reading
Syndicated Reports
Innovations in Drug Pricing and Reimbursement 2020
Healthcare Reimbursement Market Value forecast, New Business Opportunities and Companies: Outlook by Type, Application, by End User and by Country, 2020-2026
White Papers
Interventional Studies
Virtual Expanded Access Program Providing Breast Cancer Patients Early Access to Treatment During the COVID-19 Pandemic
  Assistant/Associate Director - Oncology Medical Communications (Remote) Divider Analyst/Manager, Evidence Synthesis and Meta-Analyses (Remote) Divider Assistant Professor Health Services Administration Divider Life Sciences Practice Managing Consultant – Market Access HEOR More Jobs  
Post a Job
Partner Banner
Genesis ResearchPHARUF   SYAPSE
Evidera  HealthCore Evidence PartnersICON
OM1Formulary Decisions  Pharmerit   PRMA
Become a Partner
HealthEconomics Logo  

Share this newsletter!

EMAIL   Twitter   Facebook   LinkedIn